Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.

Anesthesia and analgesia - 1 Feb 2014

Riazi Sheila, Larach Marilyn Green, Hu Charles, Wijeysundera Duminda, Massey Christine, Kraeva Natalia

Abstract excerpt

BACKGROUND: Between 1992 and 2011, 373 Canadian individuals with adverse anesthetic reaction were referred to the Malignant Hyperthermia Unit in Toronto, Ontario, Canada for malignant hyperthermia (MH) diagnostic testing. We analyzed the epidemiologic characteristics of the index adverse anesthetics for those probands who were confirmed to be MH susceptible. METHODS: One hundred twenty-nine proband survivors of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anesthetics
Share to Caffeine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Canada

Share to Halothane

Share to Malignant Hyperthermia

Share to Ryanodine Receptor Calcium Release Channel

Share to Succinylcholine

Source

Identifiers

PMID: 23842196
DOI: 10.1213/ANE.0b013e3182937d8b

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.PMID 23842196Read ↗

Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.Semantic proximity Read ↗

European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility.Semantic proximity Read ↗

European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.Semantic proximity Read ↗

An Assessment of Penetrance and Clinical Expression of Malignant Hyperthermia in Individuals Carrying Diagnostic Ryanodine Receptor 1 Gene MutationsSemantic proximity Read ↗

Genetic Testing for Malignant Hyperthermia Susceptibility-Threading the Needle in the Haystack.Semantic proximity Read ↗

Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH).Semantic proximity Read ↗

Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.Semantic proximity Read ↗

Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.Semantic proximity Read ↗

Genetic Testing for Malignant Hyperthermia Susceptibility – Threading the Needle in the HaystackSemantic proximity Read ↗

Considerations for diverse RYR1 variants in malignant hyperthermia susceptible patients: a report of two cases.Semantic proximity Read ↗

Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.Semantic proximity Read ↗

Scientific advances in the genetic understanding and diagnosis of malignant hyperthermia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.